Literature DB >> 8485584

Predicting the cytochrome P450 mediated metabolism of xenobiotics.

K R Korzekwa1, J P Jones.   

Abstract

The cytochrome P450s play a unique role in the metabolism of xenobiotics. Characteristics which allow a vast number of foreign compounds to be metabolized by a limited number of enzymes include broad substrate specificity and broad regioselectivity. Because of their importance in both the metabolism and toxicity of drugs and environmental contaminants, efforts are being made to use computational methods to predict these biotransformation pathways. This review describes the recent progress towards the prediction of the tertiary structures of the various P450s and the determination of the electronic characteristics of substrates which determine their tendency to be oxidized by the P450s.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485584     DOI: 10.1097/00008571-199302000-00001

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  12 in total

1.  Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli.

Authors:  Robert B Vail; Michael J Homann; Imad Hanna; Aleksey Zaks
Journal:  J Ind Microbiol Biotechnol       Date:  2005-03-01       Impact factor: 3.346

2.  Line-walking method for predicting the inhibition of P450 drug metabolism.

Authors:  Matthew G Hudelson; Jeffrey P Jones
Journal:  J Med Chem       Date:  2006-07-13       Impact factor: 7.446

3.  Modification of small molecules by using cytochrome P450 expressed in Escherichia coli.

Authors:  Tomohide Uno; Atsushi Nakao; Satoko Masuda; Yuuki Taniguchi; Kengo Kanamaru; Hiroshi Yamagata; Masahiko Nakamura; Hiromasa Imaishi; Kiyoharu Oono
Journal:  J Ind Microbiol Biotechnol       Date:  2006-08-05       Impact factor: 3.346

Review 4.  Implications of pharmacogenetics for individualizing drug treatment and for study design.

Authors:  Christian Meisel; Thomas Gerloff; Julia Kirchheiner; Przemyslaw M Mrozikiewicz; Przemyslaw Niewinski; Jürgen Brockmöller; Ivar Roots
Journal:  J Mol Med (Berl)       Date:  2003-03-15       Impact factor: 4.599

5.  Comparative study of the affinity and metabolism of type I and type II binding quinoline carboxamide analogues by cytochrome P450 3A4.

Authors:  Upendra P Dahal; Carolyn Joswig-Jones; Jeffrey P Jones
Journal:  J Med Chem       Date:  2011-12-01       Impact factor: 7.446

6.  A non-destructive BFCOD assay for in vivo measurement of cytochrome P450 3A (CYP3A) enzyme activity in fish embryos and larvae.

Authors:  Elias M Oziolor; Alexis N Carey; Cole W Matson
Journal:  Ecotoxicology       Date:  2017-06-06       Impact factor: 2.823

7.  Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes.

Authors:  H Yin; M W Anders; K R Korzekwa; L Higgins; K E Thummel; E D Kharasch; J P Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 8.  Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction.

Authors:  Haiyan Li; Jin Sun; Xiaowen Fan; Xiaofan Sui; Lan Zhang; Yongjun Wang; Zhonggui He
Journal:  J Comput Aided Mol Des       Date:  2008-06-24       Impact factor: 3.686

9.  Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol.

Authors:  S W Ellis; K Rowland; M J Ackland; E Rekka; A P Simula; M S Lennard; C R Wolf; G T Tucker
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

Review 10.  Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.

Authors:  J O Miners; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.